Gastrointestinal Drugs Industry Analysis and Forecast Report 2016

1. Gastrointestinal Drugs Industry Analysis, Size, Share, Growth, Trends, and Forecast Report 2016 – 2024 Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Gastrointestinal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024” to its report offerings.The market overview section of the report comprises qualitative analysis of the overall gastrointestinal drugs market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porters five force analysis and market attractiveness analysis. Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1038220 Global Gastrointestinal Drugs Market: Overview The market overview section of the report comprises market opportunity analysis for the drug class, route of administration, drug class, distribution channel, and key industry developments has also been provided. Key industry developments include the major events occurred in past 4-5 years and are expected to occur during the forecast period which are likely to affect the market dynamics. Global Gastrointestinal Drugs Market: Segmentation The global gastrointestinal drugs market has been segmented on the basis of drug class, route of administration, drug class, distribution channel. On the basis of drug class the global gastrointestinal drugs market is segmented into acid neutralizers, antidiarrheal and laxatives, antiemetic and antinauseants, anti-inflammatory drugs,

2. biologics and others including antispasmodic etc. The acid neutralizer segment is again segmented as antacids, H2 antagonists and Proton pump inhibitors. On the basis of route of administration, the global gastrointestinal drugs market has been segmented into three types such as, oral, parenteral and rectal. Based on disorder type, the global gastrointestinal drugs market is segmented into gastro esophageal reflux disease, inflammatory bowel disease and Irritable bowel syndrome. On the basis of distribution channel, the global gastrointestinal drugs market is segmented as hospital pharmacies, retail pharmacies and online pharmacies. The market for these drug class, route of administration, disorder type, and distribution channel has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, and geographic presence and product developments. The market size and forecast in terms of revenue (US$ million), for each of these segments, and the sub-segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024. Geographically, the gastrointestinal drugs market has been classified into five segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size forecast for each region has been provided for the period 2014 to 2024, in terms of drug class, route of administration, disorder type, and distribution channel, along with the CAGR (%) for the forecast period 2016 to 2024. Global Gastrointestinal Drugs Market: Competitive Analysis The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global gastrointestinal drugs market, in terms of percentage share in 2016 (estimated) has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

3. The report concludes with the profiles of major players in the global gastrointestinal drugs market such as Takeda pharmaceutical, Valeant Pharmaceuticals International, Inc., Janssen Biotech, Inc., Bayer AG, Sanofi, AstraZeneca, Allergan Plc, GlaxoSmithKline, Abbott Laboratories, Boehringer Ingelheim GmbH and Allergan Plc., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments. The global gastrointestinal drugs market is segmented as follows: By Drug Class Acid Neutralizers Antacids H2 antagonists Proton pump inhibitors Antidiarrheal and Laxatives Antiemetic and Antinauseants Anti-inflammatory drugs Biologics By Route of Administration Oral Parenteral Rectal By Disorder Type Gastro Esophageal Reflux Disease Inflammatory Bowel Disease

4. Irritable Bowel Syndrome By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Spain Rest of Europe Asia Pacific China India Japan Australia & New Zealand Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Southern Global Middle East & Africa GCC countries South Africa

5. Read Full Report with TOC: http://www.marketresearchhub.com/report/gastrointestinal- drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2024- report.html Buy Report Now! About Market Research Hub: Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps. MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients. Contact Details: 90 State Street, Albany, NY 12207, United States Toll Free: 866-997-4948 (US-Canada) Tel: +1-518-621-2074 Email: press@marketresearchhub.com Website: http://www.marketresearchhub.com/ Follow Us on: Twitter, LinkedIn, Facebook